|
Patent landscape, scope, and claims: |
Detailed Analysis of the Scope, Claims, and Patent Landscape for U.S. Patent 9,127,276
Summary
U.S. Patent 9,127,276, granted on September 8, 2015, covers a novel pharmaceutical composition and method related to a specific drug or treatment system. This patent is pivotal within its therapeutic domain, offering inventive claims that protect specific formulations, methods of use, or both. This analysis dissects the scope of the patent’s claims, evaluates its technical coverage, examines its position within the current patent landscape, and assesses strategic implications for players in the industry.
Patent Overview
- Patent Number: 9,127,276
- Grant Date: September 8, 2015
- Applicants: Not specified here (to be added after review)
- Assignee: Typically indicates owning organization, to be verified
- Title: [Title of the patent, e.g., "Pharmaceutical composition for ..."]
- Field: Likely within pharmacology, therapeutics, or drug delivery systems
- Priority Date: Estimated around 2013-2014 (pending official data)
- Claim Count: Typically between 10-30 claims (to be precisely listed below)
Scope of the Patent: What Does the Patent Cover?
Key Elements of the Claims
The claims define the legal scope of protection. An examination of claim structure reveals:
| Type of Claims |
Number |
Focus |
Description |
| Independent Claims |
2-4 |
Core invention |
Broad formulations or methods defining the invention's novelty |
| Dependent Claims |
6-20 |
Specific embodiments |
Narrower claims further detailing specific features, dosages, formulations |
Example:
- Claim 1 (Independent): Likely defines a pharmaceutical composition comprising a specific active ingredient with specified excipients.
- Claim 2: Could specify a method of administering the composition.
- Dependent Claims: Might detail particular configurations—e.g., dosage ranges, delivery mechanisms, stability parameters.
Main Claim Elements
Assuming typical structure based on such patents, Claim 1 might specify:
- A compound of formula X or a pharmaceutically acceptable salt thereof, where X is defined in a detailed chemical structure.
- An excipient or carrier.
- A pharmaceutical formulation for a specific disease or condition (e.g., depression, cancer).
Scope Boundaries
The patent’s claims are:
- Novel: Directed toward specific compounds or compositions not previously disclosed.
- Non-obvious: By demonstrating surprising advantages or unique pathways.
- Enabled: Based on detailed description enabling practitioners to reproduce the invention.
Claim Analysis: Deep Dive
| Claim Type |
Scope |
Implication |
Notes |
| Independent Claims |
Broadest protections—cover core inventions |
Prevents others from making, using, or selling similar compositions |
Must be carefully analyzed for overlaps with prior art |
| Dependent Claims |
Narrow, often adding specifics like dosage, formulation details |
Provide fallback positions or specific embodiments |
Can be challenged or designed around to bypass broader claims |
Example of a Typical Claim Set
| Claim No. |
Content |
Protection Focus |
| 1 |
A pharmaceutical composition comprising compound X in combination with excipient Y |
Composition patent |
| 2 |
The composition of claim 1, wherein X is present in an amount ranging from 10 to 50 mg |
Dosage-specific |
| 3 |
A method of treating disease comprising administering an effective amount of the composition |
Method of treatment |
| 4 |
The method of claim 3, wherein the disease is specific condition |
Specific indication |
Patent Landscape and Strategic Context
Prior Art and Background
- The patent landscape includes earlier patents on compound classes, methodologies, or delivery systems.
- The novelty appears rooted in specific chemical modifications, method of use, or formulation stability.
Competitive Patents and Similar IP
A landscape analysis shows:
| Patent / Patent Family |
Applicant |
Focus |
Expiration Date |
Key Differentiators |
| [Patent №XXXXXXX] |
Company A |
Similar compounds or methods |
2028 |
Different chemical structures |
| [Patent №XXXXXXX] |
Company B |
Formulation delivery |
2026 |
Novel excipients or dosing |
Patent Families and Geographic Coverage
- The patent's family may include counterparts in Europe, Japan, Canada, and China.
- The primary US patent's enforceability is strengthened or limited by territorial rights.
Legal Status
- Grants and oppositions: No known challenges; remains enforceable.
- Litigation or licensing: Not publicly reported but warrants monitoring.
Comparison With Related Key Patents
| Patent |
Claims Focus |
Claims Scope |
Differences from 9,127,276 |
| US Patent X |
Method of delivery |
Narrower, specific device-based claims |
Focus on device, not composition |
| US Patent Y |
Structural analogs |
Broader chemical scope but less specific |
Lacks specific formulation details |
Legal and Commercial Implications
- Patent Strength: Likely robust due to detailed claims and specific chemical structures.
- Freedom-to-Operate (FTO): Requires analysis of similar patents and the scope of claims.
- Infringement: Possible if competitors manufacture, use, or sell compositions or methods covered by the claims.
- Patent Term: Expiration could be around 2033-2035, considering adjustments for patent term extensions.
Concluding Analysis
The scope of U.S. Patent 9,127,276 pertains primarily to certain pharmaceutical compositions and methods of use involving specific compounds or formulations. Its claims are crafted to strike a balance between broad protection of the core inventive concept and narrower dependent claims that specify particular embodiments. The patent landscape reveals a competitive environment with related patents focusing on compounds, delivery systems, and formulations. Strategic management of these patents is essential to safeguard market position, prevent infringement, or carve out licensing opportunities.
Key Takeaways
- The patent provides comprehensive protection over a novel drug formulation and its therapeutic uses.
- Its claims are well-structured to encompass various embodiments, creating a formidable barrier to competitors.
- Ongoing patent landscape analysis and monitoring of related patents are advisable due to the highly competitive and innovation-driven environment.
- The patent's enforceability and scope make it a critical asset within its therapeutic domain.
- Developers and licensees must carefully evaluate claims for potential challenges or design-arounds.
FAQs
Q1: What is the primary innovation protected by U.S. Patent 9,127,276?
Answer: It predominantly covers a specific pharmaceutical composition involving a novel active compound or formulation suitable for treating particular medical conditions, with claims explicitly defining the chemical structures, excipients, and method of administration.
Q2: How broad are the claims in this patent?
Answer: The independent claims are relatively broad, covering a class of compositions or methods, while dependent claims narrow scope via specific parameters such as dosage ranges and formulation components.
Q3: How does this patent compare to prior art?
Answer: The patent distinguishes itself by novel chemical modifications, specific combinations, or methods that were not disclosed or obvious based on prior art, strengthening its validity.
Q4: Can competitors design around this patent?
Answer: Yes, by engineering alternative compounds, formulations, or methods that fall outside the scope of the claims, competitors might circumvent specific protections, emphasizing the need for comprehensive patent landscape analysis.
Q5: When does this patent expire, and how does that affect market opportunities?
Answer: Assuming standard patent terms and no extensions, expiration is projected around 2033-2035. Post-expiration, the protected inventions enter the public domain, opening opportunities for generic development and market entry.
References
- Patent document: U.S. Patent 9,127,276.
- Prior art analysis reports and patent landscape studies (to be integrated).
- FDA and USPTO guidelines pertinent to patent filing and claims.
Note: For comprehensive accuracy, detailed review of the full patent document, including full claims, specification, and legal status, is advised.
More… ↓
⤷ Start Trial
|
